Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation
Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation
Active, not recruiting · NCT03475212 · Registry updated 2025-05-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, Epstein-Barr virus infection, Herpesviridae infectious disease, Infections, Primary Immunodeficiency Diseases, Tumor Virus Infections, adenoviridae infectious disease, cytomegalovirus infection, hereditary disease, immune system disorder, inborn error of immunity, viral infectious disease | Active, not recruiting | Phase 1 / Phase 2 | 2025-05-11 | NCT03475212 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pediatric Transplantation & Cellular Therapy Consortium | 2 |
30 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.